Justices Reverse Alito’s Partial Stay Of Generics Discovery

Law360 (March 6, 2020, 2:50 PM EST) -- The U.S. Supreme Court on Friday allowed wide-ranging discovery to move forward in the massive multidistrict litigation accusing dozens of generic-drug companies of an industrywide price-fixing conspiracy.

The high court’s one-paragraph order, vacating a stay issued Feb. 28 by Justice Samuel A. Alito Jr., offered no explanation for restarting discovery in full in the MDL from private plaintiffs and state attorneys general and noted no dissents. Justice Alito’s order had paused the part of a district court’s case management order forbidding the generic-drug makers from withholding any material based on “relevance or responsiveness.” Under the district court order they could only...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!